Healthcare -
Medical - Healthcare Plans - NYSE - US
$ 62.13
-0.167 %
$ 30.9 B
Market Cap
8.8
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Centene Corporation
| Revenue | 163 B |
| Cost Of Revenue | 128 B |
| Gross Profit | 34.6 B |
| Operating Expenses | 31.5 B |
| Operating Income | 3.18 B |
| Other Expenses | -119 M |
| Net Income | 3.29 B |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||
| Revenue | 163 071.0 | 153 999.0 | 144 547.0 | 125 982.0 | 111 115.0 | 74 639.0 | 60 116.0 | 48 382.0 | 40 607.0 | 22 760.0 | 16 560.0 | 10 863.3 | 8 667.6 | 5 340.6 | 4 448.3 | 4 102.9 | 3 364.5 | 2 919.3 | 2 279.0 | 1 505.9 | 1 000.9 | 769.7 | 461.5 | 326.6 | 221.3 | 201.4 |
| GROSS PROFIT | ||||||||||||||||||||||||||
| Cost Of Revenue | 128 436.0 | 122 458.0 | 127 891.0 | 111 783.0 | 95 899.0 | 65 796.0 | 51 695.0 | 42 581.0 | 35 063.0 | 20 014.0 | 14 656.0 | 9 654.8 | 7 962.1 | 4 402.9 | 3 743.4 | 3 450.2 | 2 697.3 | 2 385.9 | 1 880.5 | 1 232.8 | 808.5 | 8.3 | 379.5 | 270.2 | 0 | 0 |
| Gross Profit | 34 635.0 | 31 541.0 | 16 656.0 | 14 199.0 | 15 216.0 | 8 843.0 | 8 421.0 | 5 801.0 | 5 544.0 | 2 746.0 | 1 904.0 | 1 208.6 | 705.5 | 937.7 | 704.9 | 652.7 | 667.3 | 533.4 | 398.5 | 273.1 | 192.4 | 761.4 | 82.0 | 56.4 | 221.3 | 201.4 |
| OPERATING INCOME | ||||||||||||||||||||||||||
| Operating Expenses | 31 460.0 | 28 611.0 | 13 020.0 | 10 936.0 | 12 062.0 | 6 791.0 | 6 963.0 | 4 602.0 | 4 284.0 | 2 041.0 | 1 440.0 | 931.1 | 704.6 | 747.4 | 547.8 | 514.5 | 535.7 | 479.3 | 427.4 | 193.9 | 127.9 | 714.5 | 429.9 | 308.1 | 214.8 | 208.0 |
| Selling, General and Administrative Expenses | 12 400.0 | 12 563.0 | 11 589.0 | 10 166.0 | 11 343.0 | 6 533.0 | 6 752.0 | 4 446.0 | 4 137.0 | 2 041.0 | 1 440.0 | 931.1 | 704.6 | 587.0 | 547.8 | 514.5 | 444.7 | 399.7 | 346.3 | 193.9 | 127.9 | 88.3 | 50.4 | 37.9 | 32.3 | 29.8 |
| Research and Development Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 3 175.0 | 2 930.0 | 3 636.0 | 3 263.0 | 3 082.0 | 1 781.0 | 1 458.0 | 1 199.0 | 1 260.0 | 705.0 | 464.0 | 277.4 | (27.1) | 190.3 | 157.1 | 138.1 | 131.6 | 54.1 | (28.9) | 79.2 | 64.5 | 46.9 | 31.6 | 18.5 | 6.5 | (6.6) |
| PRE-TAX INCOME | ||||||||||||||||||||||||||
| Interest Income Expense | 702.0 | 725.0 | 665.0 | 665.0 | 728.0 | 412.0 | 343.0 | 255.0 | 217.0 | 43.0 | 35.0 | 27.0 | 20.5 | 20.3 | 18.0 | 16.3 | 16.7 | 15.6 | 10.6 | 4.0 | 0.7 | 0.2 | 45 K | 0 | 0 | 0 |
| Total Other Income | 1 082.0 | 668.0 | 644.0 | 29.0 | (309.0) | 1.0 | (90.0) | (65.0) | (103.0) | (8.0) | (7.0) | (8.5) | (181.6) | (28.9) | (2.8) | (0.6) | 5.1 | 9.5 | 7.3 | 6.7 | 5.8 | 5.0 | 9.5 | 3.6 | 0.7 | 1.1 |
| Pre-Tax Income | 4 257.0 | 3 598.0 | 1 962.0 | 1 813.0 | 2 773.0 | 1 782.0 | 1 368.0 | 1 134.0 | 1 157.0 | 697.0 | 457.0 | 268.9 | (11.6) | 174.9 | 154.3 | 137.5 | 136.6 | 63.6 | (21.7) | 85.9 | 70.3 | 51.9 | 41.1 | 22.0 | 7.2 | (5.5) |
| NET INCOME | ||||||||||||||||||||||||||
| Tax Provision | 963.0 | 899.0 | 760.0 | 477.0 | 979.0 | 473.0 | 474.0 | 326.0 | 599.0 | 339.0 | 196.0 | 107.1 | (0.3) | 66.5 | 59.9 | 48.8 | 52.4 | 22.4 | 22.0 | 30.2 | 26.0 | 19.5 | 15.6 | 9.1 | (0.5) | 3.9 |
| Net Income | 3 305.0 | 2 702.0 | 1 202.0 | 1 347.0 | 1 808.0 | 1 321.0 | 900.0 | 828.0 | 562.0 | 355.0 | 271.0 | 165.1 | 1.9 | 111.2 | 94.8 | 83.7 | 83.5 | 73.4 | (43.6) | 55.6 | 44.3 | 33.3 | 25.6 | 12.9 | 7.7 | (9.4) |
| EPS | 6.33 | 4.97 | 2.09 | 2.31 | 3.17 | 3.19 | 2.31 | 2.4 | 1.76 | 1.49 | 1.17 | 0.76 | 0.01 | 0.56 | 0.49 | 0.49 | 0.48 | 0.42 | 0.25 | 0.33 | 0.27 | 0.23 | 0.21 | 0.75 | 0.67 | 0.87 |